Get Sample Pages: The growth of the global non-opioid pain treatment market is majorly driven by the increasing preference for non-addictive alternatives to opioid painkillers and growing awareness about the risks and side effects associated with opioid medications. Additionally, favorable government initiatives and reimbursement policies for non-opioid therapies are also contributing to the market growth. However, high costs associated with branded non-opioid medications may hinder the market growth.
Global Non Opioid Pain Treatment Market Report Coverage Report Coverage Details Market Revenue in 2024 $78.89 billion Estimated Value by 2031 $140.56 billion Growth Rate Poised to grow at a CAGR of 8.
6% Historical Data 2019–2023 Forecast Period 2024–2031 Forecast Units Value (USD Million/Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered By Drug Type, By Indication, By Route of Administration, By Distribution Channel Geographies Covered North America, Europe, Asia Pacific, and Rest of World Growth Drivers . Rising prevalence of chronic conditions . Increased awareness about opioid epidemic Restraints & Challenges .
Side effects of existing drugs . Lack of reimbursement policies Nutraceuticals are emerging as a popular non-opioid treatment option for pain management. Products containing ingredients like turmeric, ginger, omega-3 fatty acids, and other herbs that have anti-inflammatory and pain-relieving properties are.
